Pacira Biosciences, Inc. (PCRX)
23.22
+0.04
(+0.17%)
USD |
NASDAQ |
Feb 20, 16:00
23.22
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences SG&A Expense (Quarterly) : 81.65M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 117.08M |
| CorMedix, Inc. | 36.64M |
| Krystal Biotech, Inc. | 41.45M |
| Arcutis Biotherapeutics, Inc. | 62.40M |
| ADMA Biologics, Inc. | 23.05M |